MAPT and Alzheimer disease: An upregulation of the protein, as well as its deposition in amyloid-β (Aβ) and tau aggregates, was observed in the brains of patients affected by Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD) [4,5,6].